Black Rose Industries Q3 FY20 earnings call: Revenue & Margins
Q3 FY20 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #65 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Black Rose Industries Ltd Q3 FY20 key numbers
- Revenue
- Revenue (Income from operations) for 9 months FY20: Rs. 1,862.3 million; 16% growth year-on-year.
As stated in Black Rose Industries Ltd's Q3 FY20 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.
Based on Black Rose Industries Ltd's Q3 FY20 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Revenue (Income from operations) for 9 months FY20: Rs. 1,862.3 million; 16% growth year-on-year. EBITDA for 9M FY20: Rs. 245.5 million.
From Black Rose Industries Ltd's Q3 FY20 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Revenue (Income from operations) for 9 months FY20: Rs. 1,862.3 million; 16% growth year-on-year.
- Distribution sales for 9M FY20: Rs. 1,290 million; 26% annualized sales growth compared to previous years.
- Acrylamide manufacturing: Crossed 90% capacity utilization in October 2019; current capacity 20,000 MTPA for merchant sales plus captive intermediate use.
2 more points from Black Rose Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Black Rose Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Acrylamide plant: Initial capex Rs. 369 mn; additional capacity expansion capex Rs. 32.5 mn funded from internal accruals; capacity 20,000 MTPA for merchant sales plus captive use; further expansion possible at existing site (Page 15).
- Polyacrylamide liquids plant: Capacity 40,000 MTPA (under commissioning); timelines include October 2019 - 120 MTPA, January 2020 - 6,600 MTPA (Page 20).
- Capacity expansions are phased with focus on maximizing utilization and marginal capex for incremental additions (Page 16).
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Black Rose Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Black Rose Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹104 Cr, net profit ₹9 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Black Rose Indus's management said in earlier quarters
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Black Rose Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Black Rose Industries Ltd Q3 FY20 results?
Revenue (Income from operations) for 9 months FY20: Rs. 1,862.3 million; 16% growth year-on-year. EBITDA for 9M FY20: Rs. 245.5 million.
What is Black Rose Industries Ltd share price analysis?
Black Rose Industries Ltd currently shows a neutral. The stock trades at a P/E of 18.9 with a market cap of ₹543 Cr. Investors should review the full earnings analysis for detailed insights.
Is Black Rose Industries Ltd planning capital expenditure?
Acrylamide plant: Initial capex Rs. 369 mn; additional capacity expansion capex Rs. 32.5 mn funded from internal accruals; capacity 20,000 MTPA for merchant sales plus captive use; further expansion p.
Keep Black Rose Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
